Free Trial

Xylem (XYL) Stock Forecast & Price Target

Xylem logo
$116.92 -3.85 (-3.19%)
(As of 05:45 PM ET)

Xylem - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
4
Buy
8

Based on 12 Wall Street analysts who have issued ratings for Xylem in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 4 have given a hold rating, and 8 have given a buy rating for XYL.

Consensus Price Target

$152.20
30.17% Upside
According to the 12 analysts' twelve-month price targets for Xylem, the average price target is $152.20. The highest price target for XYL is $166.00, while the lowest price target for XYL is $125.00. The average price target represents a forecasted upside of 30.17% from the current price of $116.92.
Get the Latest News and Ratings for XYL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Xylem and its competitors.

Sign Up

XYL Analyst Ratings Over Time

TypeCurrent Forecast
12/19/23 to 12/18/24
1 Month Ago
11/19/23 to 11/18/24
3 Months Ago
9/20/23 to 9/19/24
1 Year Ago
12/19/22 to 12/19/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
9 Buy rating(s)
10 Buy rating(s)
9 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$152.20$147.17$147.54$120.64
Forecasted Upside30.17% Upside20.18% Upside8.25% Upside8.12% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

XYL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

XYL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Xylem Stock vs. The Competition

TypeXylemBusiness Services CompaniesS&P 500
Consensus Rating Score
2.67
2.68
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside27.20% Upside168.24% Upside12.03% Upside
News Sentiment Rating
Positive News

See Recent XYL News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/12/2024Wolfe Research
3 of 5 stars
B. Hewitt
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Peer Perform
12/11/2024Stifel Nicolaus
4 of 5 stars
 Lower TargetBuy ➝ Buy$172.00 ➝ $166.00+32.73%
12/9/2024Citigroup
3 of 5 stars
A. Kaplowitz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$135.00 ➝ $148.00+15.60%
11/6/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Giordano
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetHold ➝ Hold$138.00 ➝ $125.00+1.12%
11/1/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$163.00 ➝ $162.00+35.02%
11/1/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$175.00 ➝ $154.00+26.46%
8/13/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Karas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$165.00+29.41%
5/31/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$147.00 ➝ $152.00+9.71%
5/29/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Eade
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$146.00 ➝ $165.00+19.75%
5/3/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$110.00 ➝ $135.00-0.73%
3/12/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$150.00+18.88%
1/4/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Market Perform
11/21/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$104.00 ➝ $120.00+19.74%
10/2/2023Melius
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$122.00+33.46%
8/29/2023Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Graham
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral
6/29/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingInitiates
2/14/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joseph C Giordano
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform$115.00 ➝ $120.00+11.99%
1/18/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$105.00 ➝ $115.00-0.86%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:14 PM ET.


Should I Buy Xylem Stock? XYL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, December 13, 2024. Please send any questions or comments about these Xylem pros and cons to contact@marketbeat.com.

Xylem
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Xylem Inc.:

  • Xylem Inc. has received multiple "buy" ratings from analysts, indicating strong confidence in its future performance. Recent upgrades from firms like Citigroup suggest a positive outlook for the stock.
  • The current stock price is $129.35, which is below the consensus target price of $150.45, suggesting potential for price appreciation as the market corrects.
  • The company reported earnings of $1.11 per share, meeting analyst expectations, which reflects stability in its financial performance.
  • Xylem Inc. has a solid market capitalization of approximately $31.43 billion, indicating it is a well-established player in its industry.
  • The firm has announced a quarterly dividend of $0.36, translating to an annualized dividend yield of 1.11%, providing a return to shareholders even in a volatile market.

Xylem
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Xylem Inc. for these reasons:

  • The company’s revenue for the latest quarter was $2.10 billion, which fell short of analyst expectations of $2.17 billion, indicating potential challenges in meeting growth targets.
  • Xylem Inc. has a relatively high P/E ratio of 37.44, which may suggest that the stock is overvalued compared to its earnings, making it a riskier investment.
  • Despite a positive earnings report, the stock has experienced fluctuations, with a recent trading volume of 1,933,552 shares, indicating volatility that could deter risk-averse investors.
  • The company’s debt-to-equity ratio of 0.19 is low, which is generally positive, but it may also indicate that the company is not leveraging debt effectively to fuel growth.
  • Analysts have mixed opinions, with three holding a "hold" rating, suggesting that not all market experts are confident in the stock's immediate prospects.

XYL Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Xylem is $152.20, with a high forecast of $166.00 and a low forecast of $125.00.

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Xylem in the last year. There are currently 4 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" XYL shares.

According to analysts, Xylem's stock has a predicted upside of 30.17% based on their 12-month stock forecasts.

Over the previous 90 days, Xylem's stock had 1 upgrade by analysts.

Xylem has been rated by research analysts at Citigroup, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, TD Cowen, and Wolfe Research in the past 90 days.

Analysts like Xylem less than other "business services" companies. The consensus rating score for Xylem is 2.67 while the average consensus rating score for "business services" companies is 2.68. Learn more on how XYL compares to other companies.


This page (NYSE:XYL) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners